Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli

Journal of Antimicrobial Chemotherapy

Volumn 56, Issue 5, 2005, Pages 948-950

  Cagliero, Cédric ^a   Mouline, Christian ^a   Payot, Sophie ^a   Cloeckaert, Axel ^a  

^a CEMAGREF   (France)

Author keywords

23S rRNA; Gene inactivation; Ketolides; Mutations; Transporters

Indexed keywords

ABC TRANSPORTER; AZITHROMYCIN; BACTERIAL PROTEIN; CIPROFLOXACIN; ERYTHROMYCIN; KETOLIDE; MACROLIDE; PROTEIN CMEA; PROTEIN CMEB; PROTEIN CMEC; RNA 23S; TELITHROMYCIN; TYLOSIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CAMPYLOBACTER COLI; GENE INACTIVATION; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MUTANT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; WILD TYPE;

ANTI-BACTERIAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CAMPYLOBACTER COLI; DRUG RESISTANCE, BACTERIAL; GENE DELETION; GENES, RRNA; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, INSERTIONAL; MUTATION; RNA, RIBOSOMAL, 23S;

EID: 27744597006     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dki292     Document Type: Article

References (11)

1. Moore JE, Corcoran D, Dooley JSG et al. Campylobacter. Vet Res 2005; 36: 351-82.
2. Padungton P, Kaneene JB. Campylobacter spp. in human, chickens, pigs and their antimicrobial resistance. J Vet Med Sci 2003; 65: 161-70.
3. Boyanova L, Gergova G, Spassova Z et al. Campylobacter infection in 682 Bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases. Diagn Microbiol Infect Dis 2004; 49: 71-4.
4. Rao D, Rao JR, Crothers E et al. Increased erythromycin resistance in clinical Campylobacter in Northern Ireland - an update. J Antimicrob Chemother 2005; 55: 395-6.
5. Taylor DE, Tracz DM. Mechanisms of antimicrobial resistance in Campylobacter In: Ketley JM, Konkel OE, eds. Campylobacter:Molecular and Cellular Biology. Norfolk, UK: Horizon Bioscience, 2005; 193-204.
6. Lin J, Akiba M, Zhang Q. Multidrug efflux systems in Campylobacter. In: Ketley JM, Konkel ME, eds. Campylobacter: Molecular and Cellular Biology. Norfolk, UK: Horizon Bioscience, 2005; 205-18.
7. Payot S, Avrain L, Magras C et al. Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. Int J Antimicrob Agents 2004; 23: 468-72.
8. van Vliet AH, Wood AC, Henderson J et al. Genetic manipulation of enteric Campylobacter species. In: Norris JR, Ribbons DW, eds. Methods in Microbiology. London: Academic Press, 1998; 407-19.
9. Payot S, Cloeckaert A, Chaslus-Dancla E. Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microb Drug Resist 2002; 8: 335-43.
10. Mamelli L, Amoros JP, Pages JM et al. A phenylalanine-arginine β-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides. Int J Antimicrob Agents 2003; 22: 237-41.
11. Franceschi F, Kanyo Z, Sherer EC et al. Macrolide resistance from the ribosome perspective. Curr Drug Targets Infect Disord 2004; 4: 177-91.